Join to View Full Profile
1240 Lee StCharlottesville, VA 22908
Phone+1 434-924-9333
Fax+1 434-244-7526
Dr. Viscuse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Viscuse is an oncologist at the University of Virginia in Charlottesville, VA. He received his medical degree from Marshall University School of Medicine. He specializes in genitourinary cancers with a focus on clinical investigation and translational research.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2022
University of Texas M.D. Anderson Cancer CenterOncology, 2022
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2016 - 2019
Marshall University Joan C. Edwards School of MedicineClass of 2016
Certifications & Licensure
VA State Medical License 2022 - 2026
TX State Medical License 2019 - 2023
MN State Medical License 2017 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Attitude, Committment, & Excellence (ACE) Award Mayo Clinic, 2017-2018
- Academic Achievement Award Marshall University Joan C. Edwards School of Medicine, 2015-2016
Publications & Presentations
PubMed
- 1 citationsImpact of Renin-Angiotensin System Inhibitors on Response to PD1/L1 Inhibitors in Patients With Metastatic Renal Cell Carcinoma.Kathryn Fortune, Soham Ali, Jack Masur, Paul Viscuse, Michael Devitt
Clinical Genitourinary Cancer. 2025-02-01 - Clinical and Genomic Features of Androgen Indifferent Prostate Cancer.Jack Masur, Aakrosh Ratan, Krzysztof Wierbilowicz, Adanma Ayanambakkam, Michelle L Churchman
International Journal of Molecular Sciences. 2025-01-15 - 1 citationsWhen You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer.Paul Viscuse, William P Skelton 4th, Michael M Devitt, Robert Dreicer
JCO Oncology Practice. 2024-10-01
Press Mentions
Paul Viscuse, MD, on Androgen-Indifferent Prostate CancersSeptember 8th, 2021
Committees
- Medical Student Representative, Curriculum Committee 2012 - 2016
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
